Posts

Pan T Cells Cytotoxicity Assay

on
0

BLINCYTO® (blinatumomab): Treatment of Acute Lymphoblastic Leukemia (ALL)

on
0

Predictive Biomarkers For Cytokine Release Syndrome (CRS) by CAR T-Cells & Immune Cell Engagers

on
0

Analytical Methods: INF-Y ELISpot for Study Of T cell Response/Activation

on
0

UniQure Hope B Clinical Trial: Etranacogene dezaparvovec (AAV5-FIX-Padua Gene Therapy) Showed Substantial Improvement in Bleeding in Subjects with Hemophilia B

on
0

HPN536 Trispecific T Cell Engagers Mesothelin Associated Cancer

on
0

HPN424-PSMA T Cell Engagers for Metastatic Prostate Cancer

on
0

NAGLAZYME (galsulfase) for Treatment of Mucopolysaccharide VI (MPS VI)

on
0

Intellia Therapeutics: Overview of Clinical Stage Pipeline

on
0

Aglucosidase (Lumizyme) for Treatment of Pompe disease (GAA Deficiency)

on
0

ONPATTRO (patisiran) small interfering RNA for Treatment of Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis

on
0

Harpoon Therapeutics is Developing TriTAC T cell Engagers

on
0

Cullinan Oncology Focuses on Immuno-oncology Therapeutic Target

on
0

Autolus Therapeutics plc is Pioneering Programmed T cell Therapies

on
0

Werewolf Therapeutics Is Developing Immunomodulatory Cancer Therapeutics

on
0

PALYNZIQ (pegvaliase-pqpz) for Treatment of Phenyketonuria

on
0

Long-Read Sequencing Technology To Investigate Viral Vector Integration into Host Genome

on
0

Illumina Nextera XT DNA Sequencing Library Preparation Kit

on
0